Serving the Value-Based Care Community
February 17, 2023
Welcome to this week's issue of VBC Newsstand brought to you by VBCExhibitHall.com
After several years of virtual JPMorgan Healthcare Conferences, the 41st annual event was back in person and in full swing. Thousands of attendees came together in San Francisco to close deals, find partners, announce big wins, and give us a preview of what’s to come in 2023 and beyond. Seventeen major health systems from across the country presented at the conference: large, national faith-based organizations like Common Spirit and AdventHealth; major regional players such as Baylor Scott & White and Intermountain; smaller regional health systems, such as INOVA; AMC-centric organizations like Indiana University Health and highly specialized providers, including musculoskeletal powerhouse, Hospital for Special Surgery. Among the stories of resilience through COVID-19 and impressive transformations to expand access through digital health, a line was drawn in the sand.
Although 2024 might seem far away, less than 6 months remain for ACOs to make 
key multimillion dollar decisions. This year requires much more planning due to the many changes that are going into effect. Foremost among them is the decision of whether to early renew to accelerate the MSSP methodology changes specified in the 2023 Medicare Physician Fee Schedule (MPFS). ACOs in competitive geographies also need to accommodate time for market defense assessment, along with participant due diligence, addition, and retention.
As 2023 dawns, strategic conversations in health care are shifting away from the pandemic’s “crisis mode” to refocus on addressing long-term needs and opportunities to improve patient outcomes. Patient engagement is an area that is consistently discussed as ripe for evolution. In an ideal world, every health care provider would be focused on patient engagement right now. The benefits of this work are clear. Engaged patients tend to have better health outcomes, are more likely to keep their chronic conditions under control, have fewer unnecessary hospital visits, and can identify serious illnesses earlier to receive treatment faster.
The Biden administration rolled out three new payment models intended to lower drug costs, including new Medicare coverage options for drugs cleared under accelerated approval. The release of the three models on Tuesday is in response to an executive order President Biden delivered last year calling for the federal government to search for ways to lower prices. “These selected models will test strategies to make it easier for Medicare patients to afford and access needed prescriptions at $2 or less, help expand access to cutting-edge cell and gene therapies for people with Medicaid, and help ensure drugs already on the market are safe and effective,” said Center for Medicare and Medicaid Innovation Director Liz Fowler in a statement.
Sponsored Webinars
UPCOMING WEBINARS:

Optimizing 2024 early renewal, track and participant selection
  • Topic: Helping ACOs make PY2024 decisions for early renewal, track and participant selection, considering the rule changes in the 2023 Medicare Physician Fee Schedule
Sponsored by: Validate Health
February 22, 2023 | 1 PM EST

Boost Financial Performance By Improving Patient Outcomes
  • Topic: A case study with Aledade for maximizing savings, reducing timelines, and lowering costs by improving patient outcomes
Sponsored by: Healthjump
February 23, 2023 | 1 PM EST

How Transformative Laboratory Services Close Gaps in Care
and Reduce Cost
  • Topic: How diagnostic laboratory services drive key healthcare decisions and how to optimize actionable data to help close gaps in care and reduce cost
Sponsored by: BioReference
February 28, 2023 | 1 PM EST


RECORDED WEBINARS:

Addressing Social Determinants of Health in Your Community with a
No-Cost Tool
  • Topic: SDOH, health equity initiatives, and creating your own health equity strategy to address unmet needs and reduce avoidable admissions
Sponsored by: CareSignal

Closing the Gaps: The REACH Model, Population Health, and the Diabetic Eye Exam
  • Topic: How point-of-care testing for the diabetic eye exam impacts health equity, quality of care, and SDOH
Sponsored by: Topcon Healthcare


Check our our Webinar Archive to view past webinars on a variety of value-based care related topics!
Upcoming Conferences
RISE National 2023
March 6-8, 2023 | Colorado Springs, CO

ViVE 2023
March 26-29, 2023 | Nashville, TN

2023 Virtual Fourth National Medicare Advantage Summit
April 25-28, 2023 | Virtual

APG Annual Spring Conference 2023: Going the Distance
May 31-June 2, 2023 | San Diego, CA
EXHIBITOR SPOTLIGHT
⭑⭑⭑ NEWLY LISTED! ⭑⭑⭑
Propeller Health is a precision digital health company on a mission to uplift every person living with chronic disease so they can take control of their health. We power motivating, care-connected patient journeys and unify value for all stakeholders. In more than 150 peer-reviewed abstracts and publications, our FDA-cleared digital therapeutic platform – which includes inhaler sensors, a digital patient experience, a clinician insights portal for remote monitoring, and tailored patient support – demonstrates improved quality of life and clinical outcomes.
Platinum Level Exhibitors
Thank you to our Platinum Level exhibitors. These organizations offer the absolute highest quality products & services to the ACO & IPA community. To learn more & visit their interactive booths, click on the logos below:
Gold Level Exhibitors
Thank you to our Gold Level exhibitors. To learn more & visit their interactive booths, click on the logos below:
Feature your organization here! -- Find out How

Our thoughts and prayers are with the people of Ukraine.